EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients

Ângela Carvalho-Gomes iD, Tsveta Vladi Valcheva Valcheva, Iván Sahuco, Enrique Vidal, Laura Martínez-Arenas iD, Carmen Vinaixa, Victoria Aguilera, Sónia García García, Marina Berenguer iD

United European Gastroenterology Journal · 2024

DOI: 10.1002/ueg2.12571 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Ângela Carvalho-Gomes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology, Hepatobiliopancreatic Surgery and Transplant Group, La Fe Health Research Institute (IIS La Fe), Valencia, Spain. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Sustained Virologic Response. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Gilead Research Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Several hepatocellular carcinoma (HCC) risk‐models have been developed to individualise patient surveillance following sustained viral response (SVR) in Hepatitis C Virus patients. Validation of these models in different cohorts is an important step to incorporate a more personalised risk assessment in clinical practice. We aimed at applying these models to stratify the risk in our patients and potentially determine cost‐saving associated with individualised HCC risk‐stratification screening strategy.

Methods

Patients with baseline F3‐4 fibrosis treated with new oral direct‐acting antivirals who had reached a SVR were regularly followed as part of the HCC surveillance strategy. Six models were applied: Pons, aMAP, Ioannou, HCC risk, Alonso and Semmler. Validation of the models was performed based on sensitivity and the proportion of patients labelled as “high risk”.

Results

After excluding 557 with less than 3 fibrosis, 12 without SVR, 18 with a follow up (FU)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntiviral AgentsSustained Virologic ResponseHepatitis C, ChronicHumansMaleFemaleMiddle AgedRisk AssessmentAgedLiver CirrhosisHepacivirusRisk Factors

Stichwörter der Autor:innen

HCC‐modelsHepatitis C Virushepatocellular carcinomapatient monitoringsustained viral response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Hepatology, Hepatobiliopancreatic Surgery and Transplant Group, La Fe Health Research Institute (IIS La Fe), Valencia, Spain.
  • National Institute for the Study of Liver and Gastrointestinal Diseases, CIBEREHD, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Medicine Department, University of Valencia, Valencia, Spain.
  • Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.
  • Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.
  • Department of Biotechnology, Universitat Politècnica de València, Valencia, Spain.

ORCID-Profile: Ângela Carvalho-Gomes, Laura Martínez-Arenas, Marina Berenguer

Förderung

  • Instituto de Salud Carlos III
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
  • Gilead Research Scholars

Zitieren

APA

Carvalho-Gomes, Â., Valcheva Valcheva, T. V., Sahuco, I., Vidal, E., Martínez-Arenas, L., Vinaixa, C., Aguilera, V., García García, S., & Berenguer, M. (2024). External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12571

Vancouver

Carvalho-Gomes Â, Valcheva Valcheva TV, Sahuco I, Vidal E, Martínez-Arenas L, Vinaixa C, et al. External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12571

BibTeX
@article{CarvalhoGomes2024,
  author = {Carvalho-Gomes, Ângela and Valcheva Valcheva, Tsveta Vladi and Sahuco, Iván and Vidal, Enrique and Martínez-Arenas, Laura and Vinaixa, Carmen and Aguilera, Victoria and García García, Sónia and Berenguer, Marina},
  title = {External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3‐F4 patients},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  doi = {10.1002/ueg2.12571}
}
Kostenlos starten →